|
|||||
|
|
miR-200c Sensitizes Breast Cancer Cells to Doxorubicin Treatment by Decreasing TrkB and Bmi1 Expression |
|
| Authors: | Florian Kopp Prajakta S. Oak Ernst Wagner Andreas Roidl |
| Affiliation: | Pharmaceutical Biotechnology, Department of Pharmacy, Ludwig-Maximilians-Universität München, Munich, Germany.; King Faisal Specialist Hospital & Research center, Saudi Arabia, |
| Abstract: | |
| Keywords: | |